Email Print This Page Comment bookmark
Font : A-A+

General Information on Arformoterol Tartrate Inhalation

Generic Name : Arformoterol Tartrate Inhalation

Pronunciation : AR-for-MOE-ter-ol TAR-trate

Latest prescription information about Arformoterol Tartrate Inhalation. Learn how to pronounce the drug's name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, warnings and its storage instructions . Also listed are the International and Indian trade name(s) of the drug and its price list.
ICD Code : Y55.6 | Therapeutic Classification : Anti- Asthmatics

Trade Names/Brand Names of Arformoterol Tartrate Inhalation

India : 

International : 


Why is Arformoterol Tartrate Inhalation Prescribed? (Indications)

This medication is a long-acting beta-agonist bronchodilator, prescribed for chronic obstructive pulmonary disease (COPD). 

When should Arformoterol Tartrate Inhalation not to be taken? (Contraindications)

Contraindicated in patients with asthma, and hypersensitivity.

What is the dosage of Arformoterol Tartrate Inhalation?

Inhalation- The recommended dose is one 15-mcg unit-dose vial administered twice daily (morning and evening).

How should Arformoterol Tartrate Inhalation be taken?

It comes as a nebulizer for oral inhalation.

What are the warnings and precautions for Arformoterol Tartrate Inhalation?

Caution should be exercised in patients with history of history of other breathing problems (eg, asthma), diabetes, heart or liver disease, high blood pressure, low blood potassium levels, seizures, overactive thyroid, irregular heartbeat, overexcitement, who are taking or have taken monoamine oxidase inhibitor (MAOI) within the last 14 days, any allergy, during pregnancy and breastfeeding.

It may cause dizziness, do not drive a car or operate machinery while taking this medication.

Monitor blood sugar, lung function and blood potassium levels regularly while taking this medication.

What are the side effects of Arformoterol Tartrate Inhalation?

   Body as a Whole : Abscess, allergic reaction, digitalis intoxication, fever, hernia, injection site pain, neck rigidity, neoplasm, pelvic pain and retroperitoneal hemorrhage.
   Heart : Blood clots in veins, abnormal heart rhythm, congestive heart failure, heart block, heart attack, prolonged QT interval and fast heart rate.
   Gastrointestinal : Constipation, stomach inflammation, blood in stool, mouth infection, periodontal abscess and rectal bleeding.
   Metabolic : Dehydration, fluid renetention, decreased glucose tolerance levels, gout, increase or decrease in blood glucose.
   Musculoskeletal : Joint pain/inflammation, bone disorder, rheumatoid arthritis.
   Central Nervous System : Agitation, stroke, decreased body movement, paralysis, drowsiness and tremor.
   Respiratory : Lung cancer, respiratory disorder and voice alteration.
   Skin : Dry skin, herpes simplex, herpes zoster, skin discoloration and skin hypertrophy.
   Eye : Abnormal vision and glaucoma.
   Genitourinary : Breast cancer, calcium crystalluria (presence of calcium phosphate crystals in urine sediment), blood in urine, kidney stone, night time urination, increase PSA levels, pus in urine, urinary tract disorder and urine abnormality.

What are the other precautions for Arformoterol Tartrate Inhalation?

Avoid excess dosage.

What are the storage conditions for Arformoterol Tartrate Inhalation?

Store the medication as directed by your physician.

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Buy Medicines (Drug) at Concessional Price from India

Drugs A - Z


Drugs Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store